Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): a double-blind, randomised, placebo-controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): a double-blind, randomised, placebo-controlled trial

Published:1998-04 Issue:4 Volume:15 Page:300-307
ISSN:1078-5884
Container-title:European Journal of Vascular and Endovascular Surgery
language:en
Short-container-title:European Journal of Vascular and Endovascular Surgery

Author:

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Surgery

Reference19 articles.

1. Buerger's disease;Colburn;Heart Disease and Stroke,1993

2. Buerger's disease (Thromboangiitis Obliterans);Mills;Ann Vasc Surg,1991

3. The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease);Olin;Circulation,1990

4. Buerger's disease: diagnosis and management;Shionoya;Cardiovascular Surgery,1993

5. Buerger's disease: current status;Mills;Vascular Medicine Review,1994

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical Limb Ischemia Due to Suspected Buerger’s Disease in an Adolescent Patient: A Case Report;Cureus;2024-04-18

2. Recent advances of oxidative stress in thromboangiitis obliterans: biomolecular mechanisms, biomarkers, sources and clinical applications;Thrombosis Research;2023-10

3. Therapeutic angiogenesis in Buerger’s disease: reviewing the treatment landscape;Therapeutic Advances in Rare Disease;2022-01

4. Outcomes of Anticoagulant Therapy with Low-Molecular-Weight Heparin (LMWH) and Warfarin for Thromboangiitis Obliterans (TAO);Current Vascular Pharmacology;2021-11

5. Endovascular Treatment of Critical Limb Ischemia in Buerger Disease (Thromboangiitis Obliterans) With Midterm Follow-Up: A Viable Option When Bypass Surgery Is Not Feasible;American Journal of Roentgenology;2021-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3